Skip to main content
. 2011 Jan 31;55(4):1717–1727. doi: 10.1128/AAC.01540-10

TABLE 2.

Antiviral activities of GRL-1388 and -1398 against laboratory PI-selected HIV-1variantsa

Virus Mean EC50 in nM ± SD (fold change)
SQV RTV NFV LPV ATV APV DRV GRL-1388 GRL-1398
HIV-1NL4-3 5.2 ± 1.7 40.4 ± 4.9 30.2 ± 3.0 27.8 ± 5.3 2.5 ± 0.8 34.3 ± 1.3 3.2 ± 0.3 3.1 ± 0.2 0.2 ± 0.1
HIV-1SQV-5μM >1,000 (192) >1,000 (>25) >1,000 (>33) >1,000 (>36) 415.0 ± 15.1 (166) 353.7 ± 12.4 (10) 30.4 ± 0.5 (10) 32.6 ± 7.5 (11) 5.7 ± 1.3 (29)
HIV-1RTV-5μM 66.3 ± 8.9 (13) >1,000 (>25) 386.4 ± 84.7 (13) 698.3 ± 87.4 (25) 32.5 ± 5.9 (13) 334.5 ± 42.5 (10) 19.9 ± 13.5 (6) 28.8 ± 1.8 (9) 3.1 ± 0.2 (16)
HIV-1NFV-5μM 24.1 ± 6.3 (5) 46.5 ± 9.4 (1) >1,000 (>33) 37.2 ± 3.3 (1) 12.3 ± 2.2 (5) 71.3 ± 10.5 (2) 2.7 ± 0.4 (1) 2.6 ± 0.4 (1) 0.1 ± 0.1 (1)
HIV-1LPV-5μM 33.5 ± 0.9 (6) >1,000 (>25) 401.6 ± 11.0 (13) >1,000 (>36) 17.0 ± 7.7 (7) 320.7 ± 23.2 (9) 4.0 ± 0.9 (1) 29.9 ± 12.5 (10) 3.5 ± 0.4 (18)
HIV-1ATV-5μM 134.3 ± 22.8 (26) >1,000 (>25) >1,000 (>33) >1,000 (>36) >1,000 (>400) 521.0 ± 124.1 (15) 6.8 ± 0.6 (2) 21.9 ± 7.7 (7) 3.1 ± 0.4 (16)
HIV-1APV-5μM 47.3 ± 2.1 (9) >1,000 (>25) >1,000 (>33) 633.2 ± 21.0 (23) 453.6 ± 12.2 (181) >1,000 (>29) 423.9 ± 6.0 (132) 475.7 ± 38.1 (153) 49.0 ± 1.1 (245)
a

The amino acid substitutions identified in protease of HIV-1SQV-5μM, HIV-1RTV-5μM, HIV-1NFV-5μM, HIV-1LPV-5μM, HIV-1ATV-5μM, and HIV-1APV-5μM compared to the consensus type B sequence cited from the Los Alamos database include L10I/N37D/G48V/I54V/L63P/G73C/I84V/L90M, L10I/M46L/I54V/V82A, L10F/K20T/D30N/K45I/A71V/V77I, L10F/M46I/I54V/V82A, L23I/E34Q/K43I/M46I/I50L/G51A/L63P/A71V/V82A/T91A, and L10F/V32I/L33F/M46L/I54M/A71V, respectively. Numbers in parentheses represent fold changes in EC50s for each isolate compared to the EC50s for wild-type HIV-1NL4-3. All assays were conducted in duplicate or triplicate, and the data shown represent mean values (±1 standard deviation) derived from the results of three independent experiments.